Cohance Lifesciences Q4 Net Profit Plummets 76% as Revenue & EBITDA Fall Due to Portfolio Shifts

Entertainment National Sports Markets Business & Economy Lifestyle World Astrology & Religion Technology Education & Jobs Auto Politics Viral Opinions

Loading more articles...

Cohance Lifesciences Q3 Net Profit Plunges 76%; Company Cites Non-Structural Issues

Cohance Lifesciences Q3 Net Profit Plunges 76%; Company Cites Non-Structural Issues

C

CNBC TV18•12-02-2026, 18:21

Cohance Lifesciences Q3 Net Profit Plunges 76%; Company Cites Non-Structural Issues

•Cohance Lifesciences reported a 76% year-on-year drop in net profit to ₹36.7 crore for Q3.
•Revenue fell by 19.5% to ₹544.5 crore, and EBITDA dropped 60% to ₹95.2 crore.
•Company attributes current softness to timing and product mix, not structural issues.
•FY26 is projected as a transition and bottoming phase due to portfolio changes and inventory normalization.
•Leadership appointments completed to enhance functional depth across key areas.

Read Full Article on Cnbc in English

✦

More like this

✦

More like this

Cohance Lifesciences Shares Soar 10% After ₹216 Crore Block Deal

Cohance Lifesciences Shares Soar 10% After ₹216 Crore Block Deal

Representational image (Image: News18)

Jyothy Labs Q3 Net Profit Dips 7.2% to Rs 81.12 Cr Amid Higher Expenses

Welspun Living Q3 Profit Plunges 99% Amid Revenue Drop, Margin Narrows

Welspun Living Q3 Profit Plunges 99% Amid Revenue Drop, Margin Narrows

EBITDA मार्जिन 24.3% रहा, जो अनुमानित 24.5% से थोड़ा कम है, लेकिन पिछले साल के 24.2% से मामूली बेहतर है.

Q3 Results: 5 Companies See Profit Decline, Mixed Performance Across Sectors

इलेक्ट्रिक व्हीकल बनाने वाली ओला इलेक्ट्रिक का दिसंबर तिमाही में कंसोलिडेटेड नेट लॉस ₹487 करोड़ रहा।

14 Stocks to Watch on Feb 16: Strong Gains Expected from Quarterly Results, Deals

Q3 Results

Q3 Results: 6 Companies Release Earnings, Zydus Life Exceeds Expectations